ClinicalTrials.gg
Drug

Sonrotoclax clinical trials

Also written BGB-11417 and Beqalzi.

studies test it
34
open now
24
in phase 3
5
first study started
2020

How each study uses sonrotoclax is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sonrotoclax studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
13 May 2026 · BEQALZI · NDA 220711 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sonrotoclax
30
B-cell Lymphoma-2 Inhibitor BGB-11417
2
Bcl-2 Inhibitor BGB-11417
2

Brand

Beqalzi
3

Development codes

BGB-11417
22

Studies by the year they started

33 studies that test it; most in 2026 (16); 1 more planned to start later

Studies that test sonrotoclax, by start year
YearStudies
20201
20213
20222
20233
20243
20255
202616

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
22
Phase 3
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 18

BeOne Medicines (13) · BeiGene (3) · Ruijin Hospital (3) · City of Hope Medical Center (2) · The First Affiliated Hospital of Soochow University (2) · Institute of Hematology & Blood Diseases Hospital, China (2) · Shanghai Jiao Tong University School of Medicine (1) · Memorial Sloan Kettering Cancer Center (1)

Often tested with

Tested in the same studies.

Zanubrutinib (7) · Obinutuzumab (3) · Azacitidine (3) · Glofitamab (1) · Gemcitabine (1) · Oxaliplatin (1) · CM336 (1) · Dexamethasone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 9

Studies that test sonrotoclax.

Studies

Open first, then newest update. How each study uses sonrotoclax is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 34

See all 34 studies that test sonrotoclax →

Given beside what is tested · 12 — sonrotoclax is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered1

Codes

What other systems call sonrotoclax · ClinicalTrials.gg INT014564

  • UNII (FDA) 30R67U9KYSSONROTOCLAXConfirmed FDA, Wikidata
  • Wikidata Q131412176sonrotoclaxConfirmed FDA, Wikidata
  • NCI Thesaurus C175489SonrotoclaxOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.